ARCHIVES

In Brief: Calabresi: Rimer: Outstanding ”For NCAB Chair; board Should Maintain Strong Leadership Role

This article is from The Cancer Letter archive.

Vol. 20 No. 36 | September 23, 1994

Download PDF Visit The Full Archive

Related Articles

$150 Mil. For Army Breast Cancer Program Urged In Letter

September 16, 1994

Ethics rules slammed by NIH scientists, institute directors, societies, Senators.

April 8, 2005

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013